US Stock MarketDetailed Quotes

IMAB I-Mab

Watchlist
  • 1.760
  • -0.005-0.28%
Close May 3 16:00 ET
  • 1.770
  • +0.010+0.57%
Post 17:30 ET
142.03MMarket Cap-770P/E (TTM)

About I-Mab Company

I-Mab operates as a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel or differentiated biologics to treat diseases with unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zang on June 30, 2016 and is headquartered in Pudong, China.

Company Profile

SymbolIMAB
Company NameI-Mab
Listing DateJan 17, 2020
Issue Price14.00
Founded2016
CEOMr. Rajkumar Kannan
MarketNASDAQ
Employees318
Securities TypeDR
ADS Ratio10.0 : 23.0
Fiscal Year Ends12-31
AddressNew Bund Center,555 West Haiyang Road,55th-56th Floor
CityPudong
ProvinceShanghai
CountryChina
Zip Code201210
Phone86-21-6057-8000
Websitehttp://www.i-mabbiopharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Rajkumar Kannan
  • Chief Executive Officer and Director
  • --
  • Joseph Skelton
  • Chief Financial Officer
  • --
  • Dr. Pamela M. Klein, M.D.
  • Interim Chairman of the Board
  • --
  • Wei Fu
  • Director
  • --
  • Dr. Ruyi He, M.D.
  • Independent Director
  • --
  • Chia-hung Conor Yang
  • Independent Director
  • --
  • Dr. Rong Shao, PhD
  • Independent Director
  • --
  • Shuai Chen
  • Independent Director
  • --
  • Chun Kwok Alan Au
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg